ABX— AI Stock Forecast & Price Targets
Published 7/1/2026 · A free sample of K3vl4r’s AI-powered analysis.
Kronos price forecasts, scored fundamentals & technicals, and a multi-horizon plan.
View the live ABX price forecast →
ABX shows strong growth momentum driven by AI platform launches and strategic alliances, but elevated short interest and recent earnings volatility create near-term risk. The forecast band suggests potential upside to 10.585 with support at 7.062, though valuation metrics indicate a premium for growth.
Hold near $10.75 with support at $7.062; invalidation below $7.062 triggers a sell. Avoid sizing swing trades due to poor forecast accuracy (MAPE 18% for 1d).
Target $13.81 on earnings growth and AI platform adoption, but monitor short interest and earnings revisions. Catalyst: Q3 earnings report showing improved margins or new partnerships.
Terminal value driven by AI-driven life solutions; structural risk is regulatory shifts in insurance tech. Long-term upside depends on market acceptance of LifeARC platform and expansion into global markets.
Revenue grew 82.95% YoY with robust gross margins (81.70%) and operating margins (35.59%), driven by AI platform launches (LifeARC) and strategic alliances with Manning & Napier. Forward P/E of 9.43 is attractive versus sector averages, but high debt-to-equity (80.76) and short interest (12.18x) raise concerns. Strong cash flow ($82.4M FCF) supports growth initiatives, though recent earnings revisions show mixed signals with a Zacks #2 rating indicating optimism but no clear catalyst for further gains.
The chart shows a strong uptrend from $4.80 to $10.585 (current price), with the forecast band suggesting resistance at 10.585 and support at 7.062. The recent spike to 10.585 aligns with news of AI platform launches, but the model's directional accuracy is poor (1d: 24% vs naive baseline). Momentum appears strong in the short term, though the forecast band narrows below $9.00, indicating potential consolidation.
Key positive catalysts include the LifeARC AI platform launch and strategic alliance with Manning & Napier, which could drive growth. However, recent earnings revisions show mixed signals (Zacks #2 rating but no clear catalyst for further gains), and short interest at 18.22% suggests potential downside pressure. The court ruling against Coventry First is positive but not material to the core business.
- AI-powered LifeARC platform integration with Manning & Napier alliance (Q1 2026 earnings call)
- Strategic investment in Manning & Napier to expand AI-driven life solutions
- Earnings volatility from mixed analyst revisions
- High short interest (18.22%) creating downside pressure
- Regulatory risk around AI-driven insurance products
Get AI analysis on any stock
This is one of hundreds of Kronos AI reports — scored fundamentals & technicals, bull/base/bear price targets, a multi-horizon plan, and continuously-updated forecasts across the market. Create a free account to explore them all.
Create your free account →Already a member? Sign in · Join our Discord